Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles A Enke

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Journal of Oncology Practice|April 11, 2019
Times Not to Forget Radiotherapy When Treating Patients With LymphomaCharles A Enke
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 21, 2002
Intensity-modulated radiation therapy (IMRT): the radiation oncologist's perspectiveWeining Zhen, Robert B Thompson, Charles A Enke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Emerging role of platelet-derived growth factor receptor-beta inhibition in radioimmunotherapy of experimental pancreatic cancerJanina Baranowska-Kortylewicz, Michio Abe, Jessica Nearman, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 3, 2016
Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume?Vivek Verma, Shifeng Chen, Sumin Zhou, et al.
Cancers|November 12, 2013
Activation of PDGFr-β Signaling Pathway after Imatinib and Radioimmunotherapy Treatment in Experimental Pancreatic CancerMichio Abe, Zbigniew P Kortylewicz, Charles A Enke, et al.
Molecular Cancer Therapeutics|January 30, 2004
Role of polymorphonuclear leukocytes, nitric oxide synthase, and cyclooxygenase in vascular permeability changes induced by C5a agonist peptidesTakashi Kurizaki, Michio Abe, Sam D Sanderson, et al.
American Journal of Clinical Oncology|December 3, 2009
Temporal and regional variations in the use of preoperative radiation therapy for rectal cancerChi Lin, Mary E Charlton, Jane L Meza, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|March 23, 2006
Ultrasound-based guidance of intensity-modulated radiation therapyAlbert Y C Fung, Komanduri M Ayyangar, David Djajaputra, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 21, 2002
Clinical implementation of intensity-modulated radiation therapyCheng B Saw, Komanduri M Ayyangar, Weining Zhen, et al.
Physics in Medicine and Biology|April 22, 2005
Cell-phone interference with pocket dosimetersDavid Djajaputra, Ramasamy Nehru, Philip M Bruch, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Journal of Oncology Practice|April 11, 2019
Times Not to Forget Radiotherapy When Treating Patients With LymphomaCharles A Enke
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 21, 2002
Intensity-modulated radiation therapy (IMRT): the radiation oncologist's perspectiveWeining Zhen, Robert B Thompson, Charles A Enke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Emerging role of platelet-derived growth factor receptor-beta inhibition in radioimmunotherapy of experimental pancreatic cancerJanina Baranowska-Kortylewicz, Michio Abe, Jessica Nearman, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 3, 2016
Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume?Vivek Verma, Shifeng Chen, Sumin Zhou, et al.
Cancers|November 12, 2013
Activation of PDGFr-β Signaling Pathway after Imatinib and Radioimmunotherapy Treatment in Experimental Pancreatic CancerMichio Abe, Zbigniew P Kortylewicz, Charles A Enke, et al.
Molecular Cancer Therapeutics|January 30, 2004
Role of polymorphonuclear leukocytes, nitric oxide synthase, and cyclooxygenase in vascular permeability changes induced by C5a agonist peptidesTakashi Kurizaki, Michio Abe, Sam D Sanderson, et al.
American Journal of Clinical Oncology|December 3, 2009
Temporal and regional variations in the use of preoperative radiation therapy for rectal cancerChi Lin, Mary E Charlton, Jane L Meza, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|March 23, 2006
Ultrasound-based guidance of intensity-modulated radiation therapyAlbert Y C Fung, Komanduri M Ayyangar, David Djajaputra, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 21, 2002
Clinical implementation of intensity-modulated radiation therapyCheng B Saw, Komanduri M Ayyangar, Weining Zhen, et al.
Physics in Medicine and Biology|April 22, 2005
Cell-phone interference with pocket dosimetersDavid Djajaputra, Ramasamy Nehru, Philip M Bruch, et al.
Pageof 5